BEAM CIK: 1745999

Beam Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.3
FY22:
22.5
FY23:
−149
FY24:
−347
FY25:
−345
Change from FY21 to FY25
millions USD
FY21:
−294
FY22:
−461
FY23:
71.8
FY24:
185
FY25:
−121
Change from FY21 to FY25
millions USD
FY21:
756
FY22:
112
FY23:
276
FY24:
7.74
FY25:
478
millions USD
FY21:
396
FY22:
−327
FY23:
199
FY24:
−155
FY25:
11.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−113
FY22:
−26.4
FY23:
−183
FY24:
−356
FY25:
−360

All amounts in millions USD Data source:SEC EDGAR